ViewRay, Inc. - Common Stock (NQ:VRAY)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ViewRay, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

ViewRay Earnings Preview ↗

February 24, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About ViewRay ↗

November 18, 2022

Via Benzinga

Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 05, 2023

Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization...

Via Benzinga

ViewRay Earnings Perspective: Return On Capital Employed ↗

November 10, 2022

According to Benzinga Pro data, during Q3, ViewRay (NASDAQ:VRAY) posted sales of $26.49 million. Earnings were up 5.52%, but ViewRay still reported an overall loss of $26.11 million.

Via Benzinga

ViewRay's Earnings: A Preview ↗

October 31, 2022

ViewRay (NASDAQ:VRAY) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that ViewRay will report...

Via Benzinga

Where ViewRay Stands With Analysts ↗

August 03, 2022

Within the last quarter, ViewRay (NASDAQ:VRAY) has observed the following analyst ratings:

Via Benzinga

ViewRay: Q4 Earnings Insights ↗

February 24, 2022

ViewRay (NASDAQ:VRAY) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ViewRay...

Via Benzinga

Earnings Preview: ViewRay ↗

February 23, 2022

ViewRay (NASDAQ:VRAY) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

Earnings Scheduled For November 1, 2022 ↗

November 01, 2022

Companies Reporting Before The Bell • BP (NYSE:BP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 25, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 20, 2022

Via Benzinga

Cognex, Oxford Industries And Some Other Big Stocks Moving Higher On Tuesday ↗

September 20, 2022

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗

September 07, 2022

Via Benzinga

ViewRay: Q2 Earnings Insights ↗

August 02, 2022

ViewRay (NASDAQ:VRAY) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ViewRay reported in-line EPS of $-0.15...

Via Benzinga

Earnings Preview For ViewRay ↗

August 01, 2022

ViewRay (NASDAQ:VRAY) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that ViewRay will report...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 10, 2022

Gainers bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day...

Via Benzinga

Insider Buying Remains Elevated For A Second Week $SBUX $UBER $RILY ↗

May 16, 2022

In an unusually volatile week, we saw significant market weakness earlier in the week probably driven by forced selling and a relief rally in the end. Insiders once again stepped up their purchases to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 05, 2022

Gainers

Via Benzinga

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

90 Biggest Movers From Yesterday ↗

May 13, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

58 Stocks Moving In Thursday's Mid-Day Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Via Benzinga

Earnings Scheduled For May 5, 2022 ↗

May 05, 2022

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 27, 2022

Wednesday's session saw 784 companies set new 52-week lows.

Via Benzinga

ViewRay's MRI-Guided Stereotactic Body Radiotherapy Shows Favorable Toxicity Profile In Prostate Cancer ↗

March 10, 2022

ViewRay Inc (NASDAQ: VRAY) has announced the first toxicity results from the Phase 2 SCIMITAR trial assessing stereotactic body radiation therapy (SBRT) in prostate...

Via Benzinga

ViewRay's MRIdian MRI-Guided Imaging System Signal Superiority For Localized Prostate Cancer ↗

February 15, 2022

ViewRay Inc (NASDAQ: VRAY) has announced interim data from the single-center Phase 3 MIRAGE trial comparing MRIdian MRI-guided vs. CT-guided SBRT for localized...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 16, 2021

Gainers Calliditas Therapeutics (NASDAQ:CALT) stock rose 41.09% to $26.3 during Thursday's pre-market session. The market value of their outstanding shares is at $688....

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 17, 2021

Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.